RNA Supply Chain Videos
-
Defining Phase-Appropriate GMP Principles: Where Do We Start?
In this excerpt from Advancing RNA Live's Got Raw Materials? The State Of The mRNA Supply Chain featured guests share how they and their teams align around the definition of “phase-appropriate.”
-
Next Generation GMP Facility For CRISPR Based Therapies
3/14/2023
Explore a state-of-the-art GMP facility focused on CRISPR based Cell and Gene therapies with helping temperature controlled warehouse and multiple synthesis suites.
-
mRNA Raw Materials To Scale Up Your Manufacturing
11/22/2022
Learn more about CustomBiotech's mRNA raw materials pipeline and strict quality criteria that are designed to support the success of our customers’ manufacturing scale-up and regulatory drug approval.
-
Plasmid DNA Downstream Purification Process
4/11/2023
Large scale production of plasmid DNA requires an in-depth understanding and optimization of the entire downstream process. Explore a complete solution, from harvest to bulk filtration.
-
What Does 2025 (And Beyond) Hold For The RNA-LNP Space?
12/4/2024
Three LNP experts share their thoughts on the incremental advancements they’d like to see the RNA-LNP space make in the next few years.
-
Enabling GMP Production Of sgRNA For CRISPR-Based Cell And Gene Therapies
10/28/2024
Explore critical steps and key regulatory requirements for developing CRISPR therapeutics and gain practical advice on how to avoid common pitfalls.
-
Single-Use Technology For Quality mRNA Manufacturing
Learn how single-use technologies deliver important benefits for mRNA manufacturing, including increased speed, quality, flexibility, and adaptability to different dosages and scale-up strategies.
-
Analytical Limitations In Assessing Plasmid Quality for mRNA Production
4/11/2025
There remain a lot of gaps in our understanding of plasmid quality, particularly for high-quality mRNA production (as opposed to viral vector production). In this segment of a recent Advancing RNA Live panel, speakers Adi Nair, Tyler Goodwin, and April Sena highlight their biggest questions around plasmid DNA quality, as well as the pros and cons of some of the analytical methods upon which we’re relying most heavily today to assess plasmid quality.
-
The Way Forward: Supply Chain Solutions
10/24/2024
Learn how to build a resilient supply chain to navigate today's complex environment. Expert speakers share insights on optimization, innovation, and strategic planning to meet evolving market conditions.
-
The State of the Linear mRNA Supply Chain—In Brief
In this clip, Sanofi’s Greg Troiano kickstarts our discussion on some of the advances he’s seen in the supply chain for linear mRNA-LNP products, both in terms of supply availability and supplier capability.